Trending Now
Allogene Therapeutics Inc (NASDAQ: ALLO) Announces Publication of Anti-BCMA CAR T...
Allogenic Therapeutics Inc (NASDAQ: ALLO) has announced that preclinical trial results for its anti-BCMA CAR T cells have been published in the Cancer Research...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
CMS Grants NTAP For Nabriva Therapeutics PLC (NASDAQ:NBRV)’s XENLETA For Injection
CMS (Centers for Medicare & Medicaid Services) issued NTAP (new technology add on payment) for Nabriva Therapeutics PLC (NASDAQ:NBRV)’s XENLETA. NTAP is used for...
MAKE IT MODERN
LATEST REVIEWS
Cassava Sciences (SAVA stock) Soars on Executive Chairman’s Open Letter
Today was a thrilling day for investors in Cassava Sciences, Inc. (NASDAQ: SAVA). The company's stock surged by an impressive 27.28%, closing...
MAKE IT MODERN
PERFORMANCE TRAINING
Moleculin Biotech Inc. (NASDAQ:MBRX) Granted Three Rare Paediatric Disease Designations For WP1066
Moleculin Biotech Inc. (NASDAQ:MBRX) has received approval from the FDA for the Rare Paediatric Disease designation application for its WP1066 drug candidate. With the...
Immunomedics, Inc. (NASDAQ:IMMU) Reports Revenues Of $20.1 Million In Q2 2020: Trodelvy Demonstrates Significant...
Immunomedics, Inc. (NASDAQ:IMMU) posted $20.1 million in revenues in Q2 2020 from the sale of Trodelvy after receiving accelerated approval from the US FDA...
Amicus Therapeutics (NASDAQ:FOLD) Granted PRIME Designation By European Medicines Agency For AT-GTX-501 In CLN6...
Amicus Therapeutics (NASDAQ:FOLD) has announced that it has received Priority Medicines designation (PRIME) from the European Medical Agency for its investigational gene therapy, AT-GTX-501,...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Receives IND Clearance For TBX-1900 for Migraine Prevention
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced that the FDA has cleared its Investigational New Drug Application supporting the commencement of the second...
The USAN Announces a Commercial Brand Name for PTI-125; Lead Drug Candidate from Cassava...
Cassava Sciences Inc. (NASDAQ:SAVA) has to deal with the everyday drastic challenges of translating novel scientific insights into new medicines. Its primary mission is...
MAKE IT MODERN
